Friends of Cancer Research Hybrid Meeting
The Next Generation of Cellular Therapies:
A Blueprint to Accelerate Development
Thank you to all that attended!
Watch the Virtual Meeting
Read the Meeting Recap
Read the Event White Paper
Monday, May 22, 2023
11:00AM EDT – 3:00PM EDT
The Four Seasons
2800 Pennsylvania Ave NW
Washington, DC 20007
Full Agenda
11:00 AM – Welcoming Remarks
11:05 AM – Fireside Chat — Steven Rosenberg, Chief of Surgery, NCI, and Arie Belldegrun, Executive Chairman and Co-Founder, Allogene Therapeutics
11:30 AM – Session 1: A Risk-Based Data Extrapolation Plan for Developing Next Generation Cell Therapies
- Patrick Hanley, Children’s National Hospital — Moderator
- Marc Better, Pharmefex
- Christine Brown, City of Hope
- Vicki Coutinho, Independent
- Michael Kalos, Next Pillar Consulting
- Ingrid Markovic, U.S. FDA
12:25 PM – Networking Lunch
1:10 PM – Session 2: Emerging Considerations for Next Generation Cell Therapies
- Jonathan Jazayeri, Kite, A Gilead Company — Moderator
- Nigel Yateman, Novartis
- Larissa Lapteva, U.S. FDA
- Jae Park, Memorial Sloan Kettering Cancer Center
- Raj Puri, Iovance Biotherapeutics
- Jennifer Yohrling, Janssen R&D
2:05 PM – Session 3: The Next Horizon for Cancer Therapies
- Margaret Anderson, Deloitte Consulting, LLC — Moderator
- Peter Marks, U.S. FDA
- Arie Belldegrun, Allogene Therapeutics
- Marc Hurlbert, Melanoma Research Alliance
- Tal Zaks, OrbiMed
3:00 PM – Concluding Remarks
Friends of Cancer Research (Friends) is proud to announce our next hybrid meeting, The Next Generation of Cellular Therapies: A Blueprint to Accelerate Development, the second in a two-meeting series focusing on cell and gene therapies.
This meeting will bring together experts in the field in-person to present development strategies and policy proposals that can facilitate rapid development, commercialization and evolution of safe and effect T-cell based immunotherapies, such as CAR-T cell therapies and other engineered T-cell therapies. Following up on our March virtual meeting which focused on exploring and presenting opportunities in the field, this meeting’s white paper and panel discussions will facilitate development of the next generation of immunotherapies and support current policy discussions between key stakeholders in drug development
This meeting builds on Friends’ previous work on Cell & Gene Therapies, and is the second of two meetings in 2023 to explore next steps in the field. Click Here for more information about the first meeting in this series, which took place on March 8th, 2023.
Register for in-person or virtual attendance above and please stay tuned for more information.
